Lynn Smiley

509 total citations
9 papers, 210 citations indexed

About

Lynn Smiley is a scholar working on Infectious Diseases, Virology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lynn Smiley has authored 9 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lynn Smiley's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and HIV/AIDS Research and Interventions (3 papers). Lynn Smiley is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and HIV/AIDS Research and Interventions (3 papers). Lynn Smiley collaborates with scholars based in United States and Switzerland. Lynn Smiley's co-authors include Michael Greenberg, Miklos Salgo, Nick Cammack, Amy Schaberg, Andrea R. Mospan, Donald J. Kellerman, Andrew H. Talal, Mika Vesanen, Rhonda G. Kost and Arlene Hurley and has published in prestigious journals such as Transplantation, JAIDS Journal of Acquired Immune Deficiency Syndromes and Reviews in Medical Virology.

In The Last Decade

Lynn Smiley

9 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Smiley United States 6 102 70 50 49 40 9 210
Souheil‐Antoine Younes United States 8 121 1.2× 47 0.7× 6 0.1× 84 1.7× 235 5.9× 10 338
Izabella Picinin Safe Brazil 7 27 0.3× 40 0.6× 12 0.2× 44 0.9× 25 0.6× 19 168
Anne-Maud Ferreira United States 8 17 0.2× 127 1.8× 32 0.6× 30 0.6× 83 2.1× 9 276
Faith Schiro United States 9 65 0.6× 59 0.8× 23 0.5× 55 1.1× 28 0.7× 12 189
Tiffany R. Butterfield United States 8 90 0.9× 60 0.9× 5 0.1× 63 1.3× 96 2.4× 12 278
R. Penny Australia 8 113 1.1× 86 1.2× 6 0.1× 39 0.8× 23 0.6× 15 233
Surekha Tennakoon Australia 9 180 1.8× 112 1.6× 5 0.1× 106 2.2× 91 2.3× 13 326
Dennis C. Copertino United States 6 15 0.1× 51 0.7× 12 0.2× 19 0.4× 57 1.4× 8 123
Borja Mora‐Peris United Kingdom 9 83 0.8× 72 1.0× 6 0.1× 28 0.6× 10 0.3× 20 139
Naomi S. Coombes United Kingdom 3 18 0.2× 65 0.9× 13 0.3× 30 0.6× 33 0.8× 7 141

Countries citing papers authored by Lynn Smiley

Since Specialization
Citations

This map shows the geographic impact of Lynn Smiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Smiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Smiley more than expected).

Fields of papers citing papers by Lynn Smiley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Smiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Smiley. The network helps show where Lynn Smiley may publish in the future.

Co-authorship network of co-authors of Lynn Smiley

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Smiley. A scholar is included among the top collaborators of Lynn Smiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Smiley. Lynn Smiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
3.
Kellerman, Donald J., et al.. (2008). Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3. Pulmonary Pharmacology & Therapeutics. 21(4). 600–607. 73 indexed citations
4.
Greenberg, Michael, Nick Cammack, Miklos Salgo, & Lynn Smiley. (2004). HIV fusion and its inhibition in antiretroviral therapy. Reviews in Medical Virology. 14(5). 321–337. 56 indexed citations
5.
Kost, Rhonda G., Arlene Hurley, Linqi Zhang, et al.. (2001). Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(4). 332–339. 9 indexed citations
6.
Talal, Andrew H., Simon Monard, Mika Vesanen, et al.. (2001). Virologic and Immunologic Effect of Antiretroviral Therapy on HIV-1 in Gut-Associated Lymphoid Tissue. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 1–7. 37 indexed citations
7.
Talal, Andrew H., Simon Monard, Mika Vesanen, et al.. (2001). Virologic and Immunologic Effect of Antiretroviral Therapy on HIV-1 in Gut-Associated Lymphoid Tissue. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(1). 1–7. 15 indexed citations
8.
Kost, Rhonda G., Arlene Hurley, Linqi Zhang, et al.. (2001). Open-Label Phase II Trial of Amprenavir, Abacavir, and Fixed-Dose Zidovudine/Lamivudine in Newly and Chronically HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(4). 332–339. 2 indexed citations
9.
Starr, Stuart E., et al.. (1984). NATURAL KILLING OF CYTOMEGALOVIRUS-INFECTED TARGETS IN RENAL TRANSPLANT RECIPIENTS. Transplantation. 37(2). 161–164. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Souheil‐Antoine Younes Breakdown of academic impact, for papers by Izabella Picinin Safe Breakdown of academic impact, for papers by Anne-Maud Ferreira Breakdown of academic impact, for papers by Faith Schiro Breakdown of academic impact, for papers by Tiffany R. Butterfield Breakdown of academic impact, for papers by R. Penny Breakdown of academic impact, for papers by Surekha Tennakoon Breakdown of academic impact, for papers by Dennis C. Copertino Breakdown of academic impact, for papers by Borja Mora‐Peris Breakdown of academic impact, for papers by Naomi S. Coombes
Rankless by CCL
2026